Global Investors Take Detour Routes to Position for CXMT IPO
Claire Weston
ChangXin Memory Technologies plans a ~$9.8 billion A-share listing, but most global funds are barred from subscribing directly — so they are piling into sponsor brokerages, supply-chain stocks, and even crypto derivatives, a proxy-trade frenzy that could reshape semiconductor capital flows across Asia.
Why can't global money buy CXMT directly — and why does it still want in?
CXMT's planned A-share IPO is sized at roughly $9.8 billion, but mainland China restricts foreign institutional participation in domestic listings.
This means → most global funds cannot subscribe; they must find proxy routes to gain exposure.
In plain terms = the ticket window is closed to you, so you buy whatever is sitting next to the door.
Where is the money flowing instead?
Sponsor brokerages moved first: CICC and CSC Financial, the IPO's lead sponsors, saw their Hong Kong-listed shares rise roughly 15% and 12% over three months — while the Hang Seng Index fell nearly 5%.
Bank of America upgraded China Merchants Securities to buy in May, citing a second-half tech rally driven partly by the CXMT listing; the stock is up 18% since mid-April.
Supply-chain plays rallied even harder: ACM Research Shanghai, Jiangsu Youke, and Naura's peer Piotech all nearly doubled in three months; the STAR 50 index gained 37% over the same period.
Crypto markets joined in: startup Trade.xyz launched a perpetual futures contract — a derivative with no expiry date — tied to CXMT, and prices jumped sharply in early Wednesday trading.
What is the bull case?
Kevin Net, fund manager at Paris-based Financière de l'Echiquier, said his firm would have considered participating but is blocked by regulation.
He noted that memory chips are a core part of the AI theme, and Chinese producers are already too significant to ignore.
This reflects a broader pattern: even when the stock itself is out of reach, global capital is finding ways to bet on China's memory sector.
What do the skeptics say?
Chauwei Yak, CEO of Singapore's GAO Capital, pushed back: memory stocks have already run up — "if you like the sector, just buy SK Hynix or Samsung; they have ADRs you can trade."
In plain terms = he sees no reason to take a detour when more liquid, more transparent alternatives already exist offshore.
This means → proxy trades are essentially paying a premium for the inability to participate directly, and whether that premium is recovered depends entirely on CXMT's post-listing performance.
Proxy-trading CXMT — smart positioning or an overpriced detour?
BULL
Scarcity drives the premium
Global funds can't buy the stock directly; proxy assets are the only door in — scarcity itself has pricing power.
The AI-memory thesis is solid
Memory chips are essential AI infrastructure; Chinese producers are gaining share — the long-term logic holds.
BEAR
The premium may be too rich
Supply-chain names nearly doubled in three months — much of the upside is already priced in before IPO day.
Direct alternatives exist
SK Hynix and Samsung trade via ADRs with better liquidity and transparency.
In plain terms = both sides have a point — scarcity can sustain a short-term premium, but if CXMT underwhelms after listing, proxy buyers will be the first to feel the pain.
What is the bigger picture?
Morgan Stanley's Pankaj Mataney wrote in a research note that China semiconductor bulls expect CXMT's market cap to reach several multiples of its IPO price.
This means → if those expectations materialize, capital flows across Asia's semiconductor sector could undergo a structural reshuffle — including outflows from leveraged ETFs linked to SK Hynix and Samsung in Hong Kong.
Whether CXMT delivers on market expectations after listing will be the defining test of whether this proxy-trade logic holds up.
Content is for reference only, not financial advice.